Modern Diagnostic IPO

Listed SME
Min Investment
₹2,88,000
3200 Shares
Min Investment
₹2,88,000 · 3200 Shares
Price Band ₹85–90
Lot Size 1600 shares
Issue Size ₹37 Cr
Listed At ₹99.50 +10.6%
Subscribed 376.97×
Listed On BSE SME

Modern Diagnostic IPO Listing Day Performance

Modern Diagnostic listed on BSE SME on 07 January 2026 at ₹99.50, a 10.56% premium over the issue price of ₹90. A retail investor allotted the minimum application of 3,200 shares (2 lots) gained ₹30,400 at the listing price.

Issue price
₹90
final price
Listing price
₹99.50
pre-open auction
Listing gain
+10.56%
+₹9.5 per share
Profit per application
+₹30,400
3,200 shares

Demand going into listing

Subscribed overall376.97×
QIB193.51×
NII702.43×
Retail342.46×
Listing price = opening price from the exchange's pre-open call auction on listing day. Watch live price

Market Sentiment

Grey Market Premium What is GMP?
+₹14
+15.6% ▼ ₹0 since last update
Est. listing —
Issue price ₹90
GMP range ₹14 – ₹16
05 Jan · ₹16 07 Feb · ₹14
Updated 07 Feb, 12:00 am IST Unofficial grey-market data
Subscription Status
QIB
193.51x
NII
702.43x
bNII (>10L)
863.37x
sNII (2-10L)
380.57x
Retail
342.46x
Total
376.97x
Updated: Mar 02, 2026 11:36 pm IST
Analysis Score 70 / 100
Data: 80%
GMP Score · 44% weight 58
Subscription Score · 38% weight 90
Financial Health · 19% weight 61
Weighted average of the parts above; updates as GMP and subscription change. not investment advice.

IPO Details

Price Band₹85–90 per equity share
Face Value₹10 Per Equity Share
Lot Size 1600 shares (Min 2 lots · ₹2,88,000)
Total Issue Size ₹37.00 crore
Fresh IssueEntire issue — no offer for sale, so all proceeds go to the company
Issue TypeBook Build Issue
Lead Manager Beeline Capital Advisors Pvt. Ltd.
Registrar MUFG Intime India Pvt. Ltd.
Listing atBSE SME
BSE Code544673
Listing Price₹99.50
Listing Gain+10.56%

Market Lot Size

Category Lots Shares Amount (₹)
Retail Minimum 2 3,200 ₹2,88,000
Retail Maximum 2 3,200 ₹2,88,000
S-HNI Minimum 3 4,800 ₹4,32,000
S-HNI Maximum 6 9,600 ₹8,64,000
B-HNI Minimum 7 11,200 ₹10,08,000

IPO Reservation

QIB 20.1% NII 15% Retail 35% Anchor 29.8%
Category Shares Offered Shares %
QIB7,82,40020.10%
NII (HNI)5,85,60015.04%
bNII > ₹10L3,90,40010.03%
sNII < ₹10L1,95,2005.01%
Retail13,63,20035.02%
Anchor11,61,60029.84%
Total38,92,800

Financial Analysis

Financial Data

ROE
55.21%
ROCE
36.18%
Debt/Equity
1.07
NAV/Share
₹18.84
Revenue Growth
14.75%
Profit Margin
11.38%

Financial Performance

2025 vs 2024 Revenue +14.8% Profit (PAT) +54.9% Total Assets +30.5%
Metric 2023 2024 2025 June 2025
Revenue 56.61 68.67 78.80 22.67
Expense 62.55 61.81 66.08 18.40
Profit (PAT) 5.73 5.79 8.97 3.00
Total Assets 36.54 49.49 64.57 77.86
Values in Crores (₹)

Peer Comparison

Company EPS P/E Market Cap (Cr)
Vijaya Diagnostic Centre Limited 13.92 72.36 18
Peer median P/E 72.4x across 1 listed peer

Promoters & Holding Pattern

Promoters: Mr. Devendra Singh Yadav, Mrs. Deepali Yadav, Mrs. Asha Yadav, and Mr. Jitendra Singh

Shareholding No. of Shares Holding %
Promoter Holding Pre Issue 1,10,00,000 99.99%
Promoter Holding Post Issue 1,50,99,200 72.85%

Strengths & Risks

Strengths
  • Heavily oversubscribed — 377.0x overall (final).
  • Strong institutional (QIB) demand — 193.5x.
  • Solid profit margin — 11.4%.
  • Strong return on equity — 55%.
Risks & Concerns
  • Elevated leverage — debt/equity of 1.07.
  • Lists on the exchange's SME platform, where trading is usually thinner than on the main board — selling at your price can be harder.

From this issue's live data. Not investment advice — read the RHP.

Company Information

Modern Diagnostic at a glance

From the company's description: “Modern Diagnostic & Research Centre Limited, founded in 1985, is one of the leading diagnostic and healthcare-related services providers in India.”

Modern Diagnostic is raising ₹37 crore through an IPO on the BSE SME. All of it is a fresh issue: there is no offer for sale, so every rupee raised goes to the company rather than to selling shareholders. Main stated uses of the fresh money: Funding capital expenditure for purchase of medical Equipments for diagnostic centre and laboratories (₹20.69 crore), Funding Working Capital Requirement (₹11.6 crore) and Repayment of certain outstanding borrowings availed by the Company (₹4.5 crore).

Revenue went from ₹56.61 crore in 2023 to ₹78.8 crore in 2025, up 39% over 2 years. Profit after tax went from ₹5.73 crore to ₹8.97 crore, a net margin of 11% in the latest year.

The promoters, led by Mr. Devendra Singh Yadav, hold 100% before the issue and 73% after it — a dilution of 27.1 percentage points. Debt stands at 1.07 times equity.

Written from the issue's offer-document figures shown on this page. Not investment advice.

Company Contact Information

Modern Diagnostic & Research Centre Limited., Plot No H-64,1st Floor BLK-H, Bali, Nagar City landmark near Khetar Pal, Hospital, Ramesh Nagar, West Delhi,, New Delhi, Delhi-110015, India, Email Id: [email protected]

Objects of the Issue

Purpose Amount (Cr)
Funding capital expenditure for purchase of medical Equipments for diagnostic centre and laboratories 20.69
Funding Working Capital Requirement 11.60
Repayment of certain outstanding borrowings availed by the Company 4.50
General Corporate Purpose -

Resources & Documents

Anchor Investors

Anchor Bidding Date
December 30, 2025
Shares Offered to Anchors
11,61,600
Lock-in End (30 Days, 50%)
February 04, 2026
Lock-in End (90 Days, 50%)
April 05, 2026

Modern Diagnostic IPO - Quick Take

Modern Diagnostic has set a price band of Rs 85–Rs 90 per share for an issue size of Rs 37 crore. The stock listed with a 10.56% gain versus its issue price on January 07, 2026.

The issue is promoted by Mr. Devendra Singh Yadav, Mrs. Deepali Yadav, Mrs. Asha Yadav, and Mr. Jitendra Singh with Beeline Capital Advisors Pvt. Ltd. acting as lead manager. Net proceeds will primarily be used towards funding capital expenditure for purchase of medical Equipments for diagnostic centre and laboratories (Rs 21 crore) and funding Working Capital Requirement (Rs 12 crore).

On fundamentals, the company is posting revenue growth of 14.8%, a profit margin of 11.4%, return on equity of 55.2% in its most recent reported period. Listed peers in this segment include Vijaya Diagnostic Centre Limited (P/E 72.36x, market cap Rs 18 crore) — useful reference points when evaluating the issue's pricing relative to where the broader sector is trading.

On our data-signal score, the combined signals for this issue currently read strong — the composite picture tilts positive, though not without some caveats. This is a summary of public data, not a recommendation to apply or skip. Past performance does not predict future returns — review the price chart and peer comparison below before trading.

Modern Diagnostic IPO: Lead Manager & Registrar Track Record

How the firm running this issue and its registrar have fared on the other IPOs we track. Each firm's figures leave out Modern Diagnostic itself, so they describe what came before it.

SME IPOs, last 12 months
  • Modern Diagnostic listed at +10.6% on day one; the median of 193 listings was +1.5% (better than 70% of them).
  • Subscribed 377x against a median of 3.98x across 192 issues (higher than 96%).
  • Average listing-day move across all 194 SME listings we track: +11.6%.
Lead manager and registrar record on other IPOs we track
Firm Other IPOs Listed at / above issue Avg move Median
Beeline Capital Advisors Pvt. Ltd. Lead manager 4 2 MB · 2 SME 100% 4 of 4 +13% +4.3%
MUFG Intime India Pvt. Ltd. Registrar 66 45 MB · 21 SME 74% 46 of 62 Check allotment →
Recent listings managed by Beeline Capital Advisors Pvt. Ltd. (4)

Best: Kratikal Tech +42.2% · Weakest: Vectras Enprocon +1%

IPOListedListing-day move
Vectras Enprocon 06 Nov 2026 +1%
Shah Investor's 06 Oct 2026 +2.4%
Kratikal Tech 07 Jul 2026 +42.2%
Om Power Transmission 17 Apr 2026 +6.3%
What a lead manager does

A SEBI-registered merchant banker that runs the issue: due diligence, drafting the offer document, setting the price band with the company, and marketing the IPO to investors.

What a registrar does

Finalises the basis of allotment, credits shares to demat accounts, releases blocked funds for unsuccessful bids and handles investor queries about the issue.

Listing-day move = exchange opening price vs issue price (band ceiling where the final price isn't recorded). Counts cover IPOs we track only. Past listings don't predict this one; this is not investment advice.

Frequently Asked Questions

Modern Diagnostic listed at Rs 99.50 on 07 January 2026, against an issue price of Rs 90 — a 10.56% premium.

+10.56% at the listing price — Rs 9.5 per share, or Rs 30,400 on the minimum retail application of 3,200 shares.

The price band of Modern Diagnostic IPO is Rs 85 to Rs 90 per share. Face value is Rs 10 per share.

The total issue size of Modern Diagnostic IPO is Rs 37 crore, comprising fresh issue of Rs 37 crore.

The lot size of Modern Diagnostic IPO is 1,600 shares. The minimum application is 2 lots (3,200 shares), requiring an investment of Rs 2,88,000.

Modern Diagnostic IPO opens for subscription on December 31, 2025 and closes on January 02, 2026. Anchor investor bidding is scheduled for December 30, 2025.

The expected allotment date for Modern Diagnostic IPO is January 05, 2026. Refunds for unsuccessful applicants are expected on January 06, 2026.

Modern Diagnostic IPO is scheduled to list on January 07, 2026 on BSE. BSE script code: 544673.

The last GMP (Grey Market Premium) recorded for Modern Diagnostic IPO before listing was +Rs 14 (+15.6% over issue price). The shares actually listed at Rs 99.5 (+10.56% versus the issue price). GMP only estimates the listing price and stops mattering once the shares trade.

Modern Diagnostic IPO was subscribed 376.97 times overall by the close of bidding — retail at 342.46x, QIB at 193.51x, NII at 702.43x.

Based on the final retail subscription of 342.46x for Modern Diagnostic IPO, the estimated retail allotment probability is approximately 0.33%. This is a low probability — approximately 1 out of every 100 retail applications may receive allotment.

The registrar for Modern Diagnostic IPO is MUFG Intime India Pvt. Ltd. After the allotment date, you can check your allotment status on the registrar's official website by entering your PAN, application number, or demat account details. Allotment status is also available on the BSE and NSE websites.

The book running lead manager(s) for Modern Diagnostic IPO are Beeline Capital Advisors Pvt. Ltd.

The promoter(s) of Modern Diagnostic are Mr. Devendra Singh Yadav, Mrs. Deepali Yadav, Mrs. Asha Yadav, and Mr. Jitendra Singh.

Modern Diagnostic IPO GMP — What It Means

Its last GMP before listing was 15.6%. Of the 26 SME IPOs we have tracked with a final GMP between 10% and 25%, 21 listed above, 3 flat and 2 below the issue price; Modern Diagnostic listed 10.6% above its issue price.

See the full Modern Diagnostic GMP history and trend, or learn how grey market premium works and how reliable it is.

Related IPO

Same sector or same stage as Modern Diagnostic
Side by side: GMP, subscription, valuation, financials and listing performance.
0 Comments

No comments yet. Be the first to share your opinion!

GMPUpdate